Please login to the form below
EMA names new head of legal service
Stefano Marino is former chair of EFPIA’s trademark committee
Stefano Marino has joined the European Medicines Agency (EMA) as head of the regulator's legal service.
An Italian national, Marino has extensive legal experience in the pahrma industry, having served as director of corporate legal and intellectual property at pharma firm Sigma-Tau since 1997.
He was also chairman of Trademark Committee at the European Federation of Pharmaceutical Industries and Associations (EFPIA) from 2005 to 2013 and a member of EFPIA's Intellectual Property Policy Committee from 1998 to 2011.
In his new role, Marino heads a department that includes head of pharmaceutical law Sandra Vanlievendael and head of legal advice and implementation of new legislation Tomasz Jablonski.
COVID-19 Updates and Daily News
Featured jobs
-
CEO, Head of Health, UK
-
Six figure salary
-
Omnichannel Strategy Consultant
-
Competitive Salary
-
CEO Pricing & Market Access, UK
-
Six figure salary
-
Senior Account Manager
-
Competitive salary offered
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Valneva COVID-19 vaccine more effective than AZ
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- Vertex moves ahead with its bid to develop a curative treatment for type 1 diabetes
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
- Biogen's ALS drug tofersen misses phase 3 endpoint
- Merck receives first breast cancer approval in Europe for Keytruda
- Benefits of COVID-19 vaccine in younger children outweigh risks, says FDA
- Call for industry innovators to join working group
- Pfizer-BioNTech booster offers 95.6% efficacy against COVID-19
- US COVID-19 booster programme expanded
- The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
- Curb your conservatism: can pharma ditch its cautious approach to creativity in comms?
- Breaking the silence: It’s time to talk about the menopause
- Valneva COVID-19 vaccine more effective than AZ
- Early knockback for AbbVie as FDA rejects Allergan eye drug
PMHub
Onyx Health Ltd
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...
Latest intelligence
- The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
- The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
- Mind the Gap – Challenging Immunisation Apathy and Misinformation
- world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
- Towards Better HCP Engagement – An Email Masterclass
- 6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....
